重组人血管内皮抑素联合肝动脉化疗栓塞对中晚期原发性肝癌患者血清血管内皮生长因子水平的影响

doi:10.3969/j.issn.1672-5069.2014.05.027

Abstract

Su Yu, Zhou Zhihong, Wang Qiang. Effects of recombinant human endostatin combined with transcatheter arterial chemoembolization on serum vascular endothelial growth factor levels in patients with advanced primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(5): 541-542.

References

[1] 钟萍,李瑶,邵迴龙,等. 肝动脉化疗栓塞加重组人血管内皮抑素治疗原发性肝癌临床观察. 实用医药杂志,2011,8（9）:787-788.
[2] Molinari M,Kachura JR,Dixon E,et al. Transarterial chemoembolisation for advanced hepatocellular carcinoma:results from a North American cancer centre. Clin Oncol（R Coll Radiol）,2006,18（9）:684-692.
[3] 彭静,邢辉,张铂,等. 重组人血管内皮抑素在原发性肝癌介入治疗中的应用. 中国医药科学,2012,5（10）:66-67.
[4] 张宝南,魏治鹏. 恩度联合肝动脉化疗栓塞对原发性肝癌血管内皮生长因子表达的影响. 海南医学,2010,21（19）:9-11.
[5] 徐强,黄优华,石红建,等. 肝动脉栓塞化疗联合恩度治疗原发性肝癌的临床研究. 实用临床医药杂志,2012,16（7）:63-65.
[6] 高爽,杨向红,范一博,等. 恩度对肿瘤上清液诱导的人脐静脉内皮细胞增殖、凋亡的影响及其机制. 现代肿瘤医学,2011,19（11）:2184-2187.
[7] 朱应合,周俭,薛忠,等. 化疗药物+恩度碘油乳剂经肝动脉栓塞治疗肝癌的临床效果. 江苏医药,2013,39（6）:676-679.
[8] Kong SY,Park JW,Lee JA,et al. Association between vascular endothelial growth factor genepoly morphisms and survival in hepatocellular carcinoma patients. Hepatology,2007,46（2）:3446-3455.
[9] Jia Y,Liu M,Cao L,et al. Recombinant human endostatin, Endostar,enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model. Eur J Gynaecol Oncol,2011,32（3）:316.
[10] 高炳玉,刘玉,夏立平,等. 重组人血管内皮抑素联合肝动脉栓塞化疗治疗中晚期肝癌的临床应用. 海南医学院学报,2010,16（12）:1569-1571.
[11] 孙涛,周立群,李艳花. 恩度联合介入治疗对肝癌血管生成抑制作用的研究. 现代肿瘤医学,2013,21（1）:122-123.
[12] 张宝南,魏治鹏. 恩度联合肝动脉化疗栓塞对原发性肝癌血管内皮生长因子表达的影响. 海南医学,2010,21（19）:9-11.
[13] 孙学栋,杜玉清,陈伟建.恩度对原发性肝癌TACE术后VEGF的影响. 实用肿瘤杂志,2013,28（1）:41-44.

[1]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[2]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[3]	Chen Xiang, Wang Baolin, Wu Chen, et al.. Efficacy of transcatheter arterial chemoembolization and radion implantation in the treatment of patients with primary liver cancer and its impact on hepatic expressions of TRF1 and TRF2 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 121-124.
[4]	Ye Xuan, Zhang Peng.. Efficacy of microwave ablation combined with transcatheter arterial chemoembolization in treatment of patients with hepatic metastasis from colorectal cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 955-958.
[5]	Wang Quanhui, Zhang Yuanhao, Yuan Shouxin, et al.. Effect of 1aparoscopic hepatectomy on peripheral blood T lymphocyte subsets and serum cytokines in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 753-756.
[6]	Jin Juan, Zhou Shoulin, Gao Jing, et al.. Application of dignity therapy combined with psychological intervention in patients with end-stage primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 805-806.
[7]	Yang Zhijun, Zhao Lijuan. Application of superb micro-vascular imaging in the evaluation of blood suply in intrahepaitc lesions in patients with primary liver cancer underwent TACE [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 509-512.
[8]	Song Linquan, Liang Zhihong. Application of high frequency electric knife in hepatectomy in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 637-638.
[9]	Fang Xudong, Fang Xiaoming, Chen Dawei, et al. Application of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in forecasting prognosis of patients with primary liver cancer underwent TACE [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 431-434.
[10]	Li Ying, Sun Bo, Wang Xin. Application of structural group psychological intervention in patients with primary liver cancer after receiving percutaneous transhepatic arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 477-478.
[11]	Shi Peng, Wang Kun, Shen Junchun, et al. Application of computed tomography scan in evaluating therapeutic effect of transcatheter arterial chemoembolization in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 253-256.
[12]	Liu Dayong, Yang Guanghua, Lu Zhaomin. Efficacy of transcatheter arterial chemoembolization combined with radiofrequency ablation and Addie injection in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 261-264.
[13]	Li Guotao, Zang Ke, Yin Rongkun. Efficacy of cytokine-induced killer,three-dimensional conformal radiotherapy and TACE in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 265-268.
[14]	Liu Shuhong, Liang Chenge, Xiang Yi, et al. Cost-efficacy of different nucleos(t)ides in the treatment of patients with hepatitis B-related primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 293-294.
[15]	Yi Jinlian, Zuo Lili, Ma Ruijie. Comprehensive nursing intervention in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 299-300.

Effects of recombinant human endostatin combined with transcatheter arterial chemoembolization on serum vascular endothelial growth factor levels in patients with advanced primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments